NAMZARIC Drug Profile, 2023
NAMZARIC Drug Profile, 2023

Author: DrugPatentWatch

Publisher: DrugPatentWatch.com

Published: 2023-08-15

Total Pages: 114

ISBN-13: 1934899704

DOWNLOAD EBOOK

NAMZARIC Drug Profile, 2023

This report focuses on NAMZARIC and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

NUCYNTA ER Drug Profile, 2023
NUCYNTA ER Drug Profile, 2023

Author: DrugPatentWatch

Publisher: DrugPatentWatch.com

Published: 2023-08-15

Total Pages: 153

ISBN-13: 1934899631

DOWNLOAD EBOOK

NUCYNTA ER Drug Profile, 2023

This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

The Best 301 Business Schools
The Best 301 Business Schools

Author: Princeton Review (Firm)

Publisher: Princeton Review

Published: 2009-10

Total Pages: 818

ISBN-13: 037542959X

DOWNLOAD EBOOK

Provides a detailed overview of the best business schools across North America, including information on each school's academic program, competitiveness, financial aid, admissions requirements, and social scenes.